Insulin-like growth factor-I stimulates IL-10 production in human T cells

Journal of Leukocyte Biology

Volumn 76, Issue 4, 2004, Pages 862-867

  Kooijman, Ron ^a   Coppens, Astrid ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Cytokines; Inflammation; Leukocytes; Th1; Th2

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; PHYTOHEMAGGLUTININ; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ISOLATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; LYMPHOCYTE CULTURE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADULT; ANIMALS; CYTOKINES; ERYTHROCYTES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-10; MIDDLE AGED; PHYTOHEMAGGLUTININS; SHEEP; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS;

BACTERIA (MICROORGANISMS);

EID: 4744357923     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0404248     Document Type: Article

References (34)

1. Kooijman, R. (2004) The growth hormone/insulin-like growth factor-I axis and the immune system. In Immunoendocrinology in Health and Disease (V. Geenen, G. Chrousos, eds.), New York, NY, Marcel Dekker, 163-193.
2. Kooijman, R., Hooghe-Peters, E. L., Hooghe, R. (1996) Prolactin, growth hormone and insulin-like growth factor-I in the immune system. Adv. Immunol. 63, 377-453.
3. Clark, R. (1997) The somatogenic hormones and insulin-like growth factor-I: stimulators of lymphopoiesis and immune function. Endocr. Rev. 18, 157-179.
4. Renier, G., Clement, I., Desfaits, A. C., Lambert, A. (1996) Direct stimulatory effect of insulin-like growth factor-I un monocyte and macrophage tumor necrosis factor-α production. Endocrinology 137, 4611-4618.
5. Kooijman, R., Coppens, A., Hooghe-Peters, E. L. (2002) Insulin-like growth factor-I inhibits spontaneous apoptosis in human granulocytes. Endocrinology 143, 1206-1212.
6. Kooijman, R., Coppens, A., Hooghe-Peters, E. L. (2003) Insulin-like growth factor-I stimulates interleukin-8 production in the promyelocytic cell line HL-60 through activation of extracellular signal-regulated protein kinase. Cell. Signal. 15, 1091-1098.
7. Che, W., Lerner-Marmarosh, N., Huang, Q., Osawa, M., Ohta, S., Yoshizumi, M., Glassman, M., Lee. J. D., Yan, C., Berk, B. C., Abe, J. (2002) Insulin-like growth factor-I enhances inflammatory responses in endothelial cells: role of Gab 1 and MEKK3 in TNF-α-induced c-Jun und NF-κB activation and adhesion molecule expression. Circ. Res. 90, 1222-1230.
8. Fernandez, M., Medina, A., Santos, F., Carbajo, E., Rodriguez, J., Alvarez, J., Cobo, A. (2001) Exacerbated inflammatory response induced by insulin-like growth factor I treatment in rats with ischemic acute renal failure. J. Am. Soc. Nephrol. 12, 1900-1907.
9. Feterowski, C., Weighardt, H., Emmanuilidis, K., Hartung, T., Holzmann, B. (2001) Immune protection against septic peritonitis in endotoxin-primed mice is related to reduced neutrophil apoptosis. Eur. J. Immunol. 31, 1268-1277.
10. Inoue, T., Saito, H., Fukushima, R., Inaba, T., Lin, M. T., Fukatsu, K., Muto, T. (1995) Growth hormone and insulinlike growth factor I enhance host defense in a murine sepsis model. Arch. Surg. 130, 1115-1122.
11. Firth, S. M., Baxter, R. C. (2002) Cellular actions of the insulin-like growth factor binding proteins. Endocr. Rev. 23, 824-854.
12. Jeschke, M. G., Herndon, D. N., Barrow, R. E. (2000) Insulin-like growth factor I in combination with insulin-like growth factor binding protein 3 affects the hepatic acute phase response and hepatic morphology in thermally injured rats. Ann. Surg. 231, 408-416.
13. Jeschke, M. G., Barrow, R. E., Herndon, D. N. (2000) Insulinlike growth factor I plus insulinlike growth factor binding protein 3 attenuates the proinflammatory acute phase response in severely burned children. Ann. Surg. 231, 246-252.
14. Cohen, P. (2001) Clinical implications of the IGF-cancer connection. Growth Horm. IGF Res. 11, 336-338.
15. Chen, W., Salojin, K. V., Mi, Q. S., Grattan, M., Meagher, T. C., Zucker, P., Delovitch, T. L. (2004) Insulin-like growth factor (IGF)-I/IGF-binding protein-3 complex: therapeutic efficacy and mechanism of protection against type 1 diabetes. Endocrinology 145, 627-638.
16. Liu, X., Linnington, C., Webster, H. D., Lassmann, S., Yao, D. L., Hudson, L. D., Wekerle, H., Krentzberg, G. W. (1997) Insulin-like growth factor-I treatment reduces immune cell responses in acute non-demyelinative experimental autoimmune encephalomyelitis. J. Neurosci. Res. 47, 531-538.
17. Lovett-Racke, A. E., Bittner, P., Cross, A. H., Carlino, J. A., Racke, M. K. (1998) Regulation of experimental autoimmune encephalomyelitis with insulin-like growth factor (IGF-I) and IGF-I/IGF-binding protein-3 complex (IGF-I/IGFBP3). J. Clin. Invest. 101, 1797-1804.
18. Tu, W., Cheung, P. T., Lau, Y. L. (1999) IGF-I increases interferon-γ and IL-6 mRNA expression and protein production in neonatal mononuclear cells. Pediatr. Res. 46, 748-754.
19. Yang, Y., Niu, J., Guo, L. (2002) The effects of antisense insulin-like growth factor-I receptor oligonucleotide on human cord blood lymphocytes. J. Mol. Endocrinol. 28, 207-212.
20. Kooijman, R., Rijkers, G. T., Zegers, B. J. M. (1996) IGF-I potentiates interleukin-2 production in human peripheral T cells. J. Endoricrinol. 149, 351-356.
21. Brocardo, M. G., Schillaci, R., Galeano, A., Kadrizzani, M., White, V., Guerrico, A. G., Santa-Coloma, T. A., Roldan, A. (2001) Early effects of insulin-like growth factor-I in activated human T lymphocytes. J. Leukoc. Biol. 70, 297-305.
22. Moore, K. W., de Waal Malefyt, R., Coffman, R. L., O'Garra, A. (2001) Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765.
23. Berg, D. J., Davidson, N., Kuhn, R., Muller, W., Menon, S., Holland, G., Thompson-Snipes, L., Leach, M. W., Rennick, D. (1996) Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J. Clin. Invest. 98, 1010-1020.
24. Cavaillon, J. M. (2001) Pro- versus anti-inflammatory cytokines: myth or reality. Cell. Mol. (Noisy-Le-Grand) 47, 695-702.
25. Robbins, K., McCabe, S., Scheiner, T., Strasser, J., Clark, R., Jardieu, P. (1994) Immunological effects of insulin-like growth factor-I-enhancement of immunoglobulin synthesis. Clin. Exp. Immunol. 95, 337-342.
26. Arkins, S., Rebeiz, N., Biragyn, A., Reese, D. L., Kelley, K. W. (1993) Murine macrophages express abundant insulin-like growth factor-I class I Ea and Eb transcripts. Endocrinology 133, 2334-2343.
27. Kooijman, R., Willems, M., Rijkers, G. T., Brinkman, A., van Buul Offers, S. C., Heijnen, C. J., Zegers, B. J. M. (1992) Effects of insulin-like growth factors and growth hormone on the in vitro proliferation of T lymphocytes. J. Neuroimmunol. 38, 95-104.
28. Jeschke, M. G., Barrow, R. E., Suzuki, F., Rai, J., Benjamin, D., Herndon, D. N. (2002) IGF-I/IGFBP-3 equilibrates ratios of pro- to anti-inflammatory cytokines, which are predictors for organ function in severely burned pediatric patients. Mol. Med. 8, 238-246.
29. Warzecha, Z., Dembinski, A., Ceranowicz, P., Konturek, S. J., Tomaszewska, R., Staehura, J., Konturek, P. C. (2003) IGF-I stimulates production of interleukin-10 and inhibits development of caerulein-induced pancreatitis. J. Physiol. Pharmacol. 54, 575-590.
30. Burtrum, D., Zhu, Z., Lu, D., Anderson, D. M., Prewett, M., Pereira, D. S., Bassi, R., Abdullah, R., Hooper, A. T., Koo, H., Jimenez, X., Johnson, D., Apblett, R., Kussie, P., Bohlen, P., Witte, L., Hicklin, D. J., Ludwig, D. L. (2003) A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo. Cancer Res. 63, 8912-8921.
31. Matsuda, M., Salazar, K., Petersson, M., Masucci, G., Hansson, J., Pisa, P., Zhang, Q. J., Masucci, M. G., Kiessling, R. (1994) Interleukin 10 pretreatment protects target cells front tumor- and allo-specific cytoloxic cells and downregulates HLA class I expression. J. Exp. Med. 180, 2371-2376.
32. Masood, R., Zhang, Y., Bond, M. W., Scadden, D. T., Moudgil, T., Law, R. E., Kaplau, M. H., Jung, B., Espina, B. M., Lunardi-Iskandar, Y. (1995) Initerleukin-10 is an autocrine growth factor for acquired immunondeficiency syndrome-related B-cell lymphoma. Blood 85, 3423-3430.
33. Lazar-Molnar, E., Hegyesi, H., Toth, S., Falus, A. (2000) Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine. 12, 547-554.
34. Otsuki, T., Yata, K., Sakaguchi, H., Uno, M., Fujii, T., Wada, H., Sugihara, T., Ueki, A. (2002) IL-10 in myeloma cells. Leuk. Lymphoma 43, 969-974.